Chung Kevin 4

What Happened
Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp (ICU), was granted 7,202 restricted stock units (RSUs) on July 1, 2026. The Form 4 reports the acquisition at $0.00 (typical for RSU grants); no cash was paid. The award will convert to common shares only as the RSUs vest according to the schedule below.

Key Details

• Transaction date and type: 2026-07-01 — Grant/Award (code A) of 7,202 RSUs reported on Form 4 filed 2026-07-02.
• Reported price: $0.00 (award reported as zero purchase price).
• Vesting schedule (footnote): RSUs vest in three equal installments on July 1, 2026; November 1, 2026; and March 1, 2027.
• Shares owned after transaction: Not disclosed in this filing.
• Timeliness: Filing appears timely (transaction dated 7/1/2026; Form 4 filed 7/2/2026).
• Taxes/withholding: No tax withholding or share withholding was reported in this filing.

Context
RSU grants are a form of compensation, not an open‑market purchase or sale. The Form 4 shows an acquisition at $0 because the award is granted by the company; the economic value to the insider depends on SeaStar’s stock price when each tranche vests and any applicable tax withholding. Investors should view awards as executive compensation (not a direct buy/sell signal) and watch future Form 4s for share deliveries or any subsequent sales.